The Viz.ai Intelligent Care Coordination Platform is the most widely used AI-powered solution to connect multidisciplinary beyond neurovascular, improving outcomes for patients and hospital economics.
Viz.ai is a San Francisco-based healthcare technology company that specializes in artificial intelligence (AI) solutions for stroke care. The company was founded in 2016 by Dr. Chris Mansi and Dr. David Golan and has since grown to become a leading player in the stroke care market.
Viz.ai’s platform uses AI algorithms to analyze medical imaging data from computed tomography (CT) scans and identify cases of suspected large vessel occlusion (LVO), which is a severe type of stroke that requires immediate intervention. The platform sends alerts to stroke specialists, enabling them to quickly review the data and make treatment decisions faster and more accurately than traditional methods.
Viz.ai’s platform has been FDA-cleared for use in the United States and has received CE marking for use in Europe. The platform is used by hospitals and healthcare providers across the United States and Europe to improve patient outcomes and reduce the time to treatment for stroke patients.
Overall, Viz.ai is a leading healthcare technology company, leveraging the power of AI to revolutionize stroke care and improve patient outcomes.